Point Therapeutics (MM) (NASDAQ:POTP)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Point Therapeutics (MM) Charts. Click Here for more Point Therapeutics (MM) Charts.](/p.php?pid=staticchart&s=N%5EPOTP&p=8&t=15)
Point Therapeutics, Inc. (NASDAQ: POTP) announced today
the pricing of 8,050,000 shares of its common stock at $3.00 per share
pursuant to an effective shelf registration statement. The net
proceeds of the public offering are expected to be approximately $22.2
million. Point has also granted the underwriters in the offering an
option to purchase up to an additional 1,207,500 shares of its common
stock to cover over-allotments, if any. All shares are being offered
by the company. The offering is expected to close on November 28,
2005. Pacific Growth Equities, LLC is the sole bookrunner with CIBC
World Markets Corp. acting as a co-lead manager in the offering.
A shelf registration relating to these shares was originally filed
with the Securities and Exchange Commission on December 17, 2004 and
has since been declared effective by the SEC on January 12, 2005. The
offering of these shares of common stock may be made only by means of
a prospectus supplement to the prospectus contained in the shelf
registration statement, which is also called the base prospectus. Such
prospectus supplement, which incorporates the base prospectus, has
been filed with the SEC, and is available on the SEC's website at
http://www.sec.gov. This press release shall not constitute an offer
to sell or the solicitation of an offer to buy, nor shall there be any
sale of these securities in any state in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state.
Copies of the prospectus supplement relating to the offering may
be obtained from Pacific Growth Equities, LLC, c/o Prospectus
Department, One Bush Street, Suite 1700, San Francisco, CA 94104,
(415) 274-6819.
Certain statements contained herein are not strictly historical
and are "forward looking" statements as defined in the Private
Securities Litigation Reform Act of 1995. This information includes
statements with respect to the anticipated proceeds from and the
closing of the public offering. Forward-looking statements are
statements that are not historical facts, and can be identified by,
among other things, the use of forward-looking language, such as
"believes," "feels," "expects," "may," "will," "should," "seeks,"
"plans," "schedule to," "anticipates" or "intends" or the negative of
those terms, or other variations of those terms of comparable
language, or by discussions of strategy or intentions. A number of
important factors could cause actual results to differ materially from
those projected or suggested in the forward looking statement,
including the risk factors described in Point's Prospectus Supplement
filed with the Securities and Exchange Commission on November 22, 2005
and from time to time in Point's periodic and other reports filed with
the Securities and Exchange Commission.